Baicalin from Scutellaria baicalensis is a major
flavonoid constituent found in the traditional Chinese medicinal herb Baikal skull cap. It has been widely used for the treatment of various diseases such as
pneumonia,
diarrhea, and
hepatitis. Recent studies have demonstrated that
baicalin possesses a wide range of pharmacological and
biological activities, including anti-inflammatory, anti-microbial,
anti-oxidant, and anti-
tumor properties. Specifically, its anti-inflammatory activity has been estimated in various animal models of acute and chronic
inflammation; however, its effects on dendritic cells (DCs) maturation and immuno-stimulatory activities are still unknown. In this study, we attempted to determine whether
baicalin could influence DC surface molecule expression,
antigen uptake capacity,
cytokine production, and capacity to induce T-cell differentiation.
Baicalin was shown to significantly suppress the expression of surface molecules CD80, CD86, major histocompatibility complex (MHC) class I, and MHC class II as well as the levels of
interleukin-12 production in
lipopolysaccharide stimulated DCs. Moreover,
baicalin-treated DCs showed an impaired induction of the T helper type 1 immune response and a normal cell-mediated immune response. These findings provide important understanding of the immunopharmacological functions of
baicalin and have ramifications for the development of therapeutic adjuvants for the treatment of DCs-related acute and
chronic diseases.